Biotechnology Stocks II Performance Guide: Renovaro Biosciences Inc. (RENB)
RENB has no dividends.
Table and Chart of RENB Performance
See what a $1,000 investment in RENB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RENB Returns | |
|---|---|
| Start Date | Mar-31-2015 |
| Start Price | $6.04 |
| End Date | May-17-2024 |
| End Price | $0.97 |
| # Prices | 111 |
| Min Date | Jun-30-2023 |
| Min Price | $0.57 |
| Max Date | Nov-30-2021 |
| Max Price | $12.55 |
| Total Return | -83.94% |
| Annualized Return | -17.94% |
| Current Value of $1,000 Purchase | $161 |
| Number Returns | 6,105 |
| Average Return | 34.89% |
| Number Profitable Returns | 2,810 |
| Percent Profitable Returns | 46.03% |
| Number Unprofitable Returns | 3,295 |
| Percent Unprofitable Returns | 53.97% |
| Profitable to Unprofitable Returns Ratio | 0.85 |
| RENB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $139,358,000 |
| Beta | 0.435 | Price to Sales |
| Earnings per Share | $-0.8000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 7.78 |
| PRICE DATA | |
| 52 Week High | $5.25 |
| 52 Week Low | $0.393 |
| Analyst Target Price | $None |
| 50-Day Moving Average | $2.249 |
| 200-Day Moving Average | $2.98 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -46% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RENB Compare Returns with S&P 500
RENB Trendline Chart
RENB Moving Average Chart
RENB Stock Return Map - See Patterns of Gains and Losses
RENB Stock Returns/Purchase Dates